Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Biochem Pharmacol. 2011 Sep 29;83(1):131–138. doi: 10.1016/j.bcp.2011.09.023

Table 2.

Median (range) maximum urine concentrations (Cmax100) and times of maximum urine concentrations (tmax100) normalized to 100 mg/dL creatinine of R- and S-stereoisomers in urine after low (1.0 mg/kg) and high (1.6 mg/kg) oral MDMA administration.

Cmax 100 (μmol/g creatinine) t max 100 (h)

R S R S

MDMA low 49.0 (15.2-277) 34.9 (9.5-144) 8.4 (3.2-13.7) 7.4 (3.2-13.4)
high 140.8 (68.4-264) 111.0 (46.6-163) 6.5 (4.0-23.2) 5.6 (3.1-11.3)

DHMA low 1.1 (0.5-5.7) 0.7 (0.2-5.3) 13.7 (2.6-87.8) 9.4 (2.6-87.8)
high 1.8 (0.4-4.3) 0.7 (0.3-4.4) 8.8 (1.2-62.4) 7.7 (0.9-23.2)

DHMA sulfate low 57.0 (21.8-115) 85.9 (18.7-185) 7.9 (2.1-17.3) 5.7 (2.1-17.3)
high 81.7 (28.3-178) 112.1 (49.3-338) 4.5 (3.1-6.3) 4.8 (4.0-6.3)

HMMA low 8.5 (0.3-21.5) 9.5 (0.4-28.0) 3.2 (1.5-7.3) 3.7 (1.5-8.5)
high 17.6 (2.3-61.6) 23.8 (4.2-96.6) 4.4 (2.9-11.3) 4.4 (2.9-11.3)

HMMA sulfate low 49.9 (23.6-122) 46.0 (12.8-137) 5.7 (2.1-17.3) 5.7 (2.1-17.3)
high 63.5 (27.2-105) 53.8 (27.4-128) 4.40 (2.9-23.0) 4.5 (3.1-5.3)

HMMA glucuronide low 31.2 (10.7-151) 51.3 (24.6-240) 4.7 (3.2-10.0) 4.7 (3.2-10.0)
high 39.5 (9.7-107) 84.3 (19.3-189) 5.2 (4.3-7.3) 5.1 (3.1-7.3)

MDA low 2.5 (1.0-13.1) 3.0 (1.1-17.5) 13.5 (6.0-34.3) 12.9 (6.0-56.4)
high 3.8 (2.1-10.1) 6.3 (3.8-12.0) 10.3 (5.0-35.2) 7.8 (5.0-35.2)